Microwave-assisted synthesis of small molecules targeting the infectious diseases tuberculosis, HIV/AIDS, malaria and hepatitis C. (Q34121361)

31 July 2017

Microwave-assisted synthesis of small molecules targeting the infectious diseases tuberculosis, HIV/AIDS, malaria and hepatitis C. (English)

1 reference

31 July 2017

0 references

1 reference

0 references

1 reference

3

Mats Larhed

1 reference

31 July 2017

Johan Gising

1

1 reference

ORCID Public Data File 2021

author name string

Luke R Odell

series ordinal

2

1 reference

31 July 2017

9 January 2012

1 reference

Organic and Biomolecular Chemistry

31 July 2017

1 reference

31 July 2017

10

1 reference

31 July 2017

14

1 reference

31 July 2017

2713-2729

1 reference

Application of commercial microwave ovens to organic synthesis

31 July 2017

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

The use of microwave ovens for rapid organic synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Controlled microwave heating in modern organic synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Controlled microwave heating in modern organic synthesis: highlights from the 2004-2008 literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Nonthermal microwave effects revisited: on the importance of internal temperature monitoring and agitation in microwave chemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Microwave-assisted Suzuki coupling reactions with an encapsulated palladium catalyst for batch and continuous-flow transformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A microreactor for microwave-assisted capillary (continuous flow) organic synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

XDR Tuberculosis — Implications for Global Public Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Efficient palladium(II) catalysis under air. Base-free oxidative heck reactions at room temperature or with microwave heating

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and preliminary biological evaluation of novel N-(3-aryl-1,2,4-triazol-5-yl) cinnamamide derivatives as potential antimycobacterial agents: an operational Topliss Tree approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Library synthesis using 5,6,7,8-tetrahydro-1,6-naphthyridines as scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A microwave-assisted, facile, regioselective Friedländer synthesis and antitubercular evaluation of 2,9-diaryl-2,3-dihydrothieno-[3,2-b]quinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Novel molecular hybrids of cinnamic acids and guanylhydrazones as potential antitubercular agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Proteasome inhibitors: Dozens of molecules and still counting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Inhibitors selective for mycobacterial versus human proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A microwave-assisted diastereoselective multicomponent reaction to access dibenzo[c,e]azepinones: synthesis and biological evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Design, microwave-assisted synthesis and HIV-RT inhibitory activity of 2-(2,6-dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and biological activity of novel 5'-arylamino-nucleosides by microwave-assisted one-pot tandem Staudinger/aza-Wittig/reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Microwave-assisted synthesis of dinucleoside analogues containing a thiazolidin-4-one linkage via one-pot tandem Staudinger/aza-Wittig/cyclization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Utilization of molybdenum- and palladium-catayzed dynamic kinetic asymmetric transformations for the preparation of tertiary and quaternary stereogenic centers: a concise synthesis of tipranavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Design and fast synthesis of C-terminal duplicated potent C(2)-symmetric P1/P1'-modified HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Microwave-enhanced and metal-catalyzed functionalizations of the 4-aryl-dihydropyrimidone template.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2' to P1/P1'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Microwave-accelerated synthesis of P1'-extended HIV-1 protease inhibitors encompassing a tertiary alcohol in the transition-state mimicking scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Two-carbon-elongated HIV-1 protease inhibitors with a tertiary-alcohol-containing transition-state mimic

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Anti-AIDS agents 79. Design, synthesis, molecular modeling and structure-activity relationships of novel dicamphanoyl-2',2'-dimethyldihydropyranochromone (DCP) analogs as potent anti-HIV agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Efficient microwave-assisted one-pot preparation of angular 2,2-dimethyl-2H-chromone containing compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

The molecular mechanism of action of artemisinin--the debate continues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A combinatorial approach to 2,4,6-trisubstituted triazines with potent antimalarial activity: combining conventional synthesis and microwave-assistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis of new 4-aminoquinolines and quinoline-acridine hybrids as antimalarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Antimalarial pyrido[1,2-a]benzimidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Novel amodiaquine congeners as potent antimalarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis, antimalarial activity, and cellular toxicity of new arylpyrrolylaminoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Original quinazoline derivatives displaying antiplasmodial properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Structure-activity relationships of 4-position diamine quinoline methanols as intermittent preventative treatment (IPT) against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Microwave-assisted ring opening of epoxides: a general route to the synthesis of 1-aminopropan-2-ols with anti malaria parasite activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis of 2-(aminomethyl)aziridines and their microwave-assisted ring opening to 1,2,3-triaminopropanes as novel antimalarial pharmacophores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A concise silylamine approach to 2-amino-3-hydroxy-indoles with potent in vivo antimalaria activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Novel peptidomimetics containing a vinyl ester moiety as highly potent and selective falcipain-2 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

The global burden of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and SAR of potent inhibitors of the Hepatitis C virus NS3/4A protease: exploration of P2 quinazoline substituents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

P2-P1' macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Novel P2-P4 macrocyclic inhibitors of HCV NS3/4A protease by P3 succinamide fragment depeptidization strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

A straightforward microwave method for rapid synthesis of N-1, C-6 functionalized 3,5-dichloro-2(1H)-pyrazinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Easy-to-execute carbonylations: microwave synthesis of acyl sulfonamides using Mo(CO)(6) as a solid carbon monoxide source.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

New developments in the discovery of agents to treat hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Optimization of Pharmacokinetics through Manipulation of Physicochemical Properties in a Series of HCV Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Discovery of novel arylethynyltriazole ribonucleosides with selective and effective antiviral and antiproliferative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Ammonia inhibits phagosome–lysosome fusion in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Acyclic Nucleoside Analogues as Inhibitors ofPlasmodiumfalciparumdUTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

Design, Synthesis, and Biological Evaluation ofPlasmodium falciparumLactate Dehydrogenase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2OB06833H

21 January 2018

Identifiers

DOI

10.1039/C2OB06833H

1 reference

31 July 2017

1 reference

PubMed ID

22227602